ConductScience.org, home
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
API referenceFor AI assistants

Trial · NCT00968708

Adverse events1,464

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

581 to 600 of 1,464

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousRespiratory failureRespiratory, thoracic and mediastinal disordersPlacebo82,679
seriousRespiratory failureRespiratory, thoracic and mediastinal disordersAlogliptin82,701
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersPlacebo82,679
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersAlogliptin72,701
seriousPulmonary embolismRespiratory, thoracic and mediastinal disordersPlacebo22,679
seriousPulmonary embolismRespiratory, thoracic and mediastinal disordersAlogliptin92,701
seriousAcute respiratory failureRespiratory, thoracic and mediastinal disordersPlacebo22,679
seriousAcute respiratory failureRespiratory, thoracic and mediastinal disordersAlogliptin72,701
seriousPulmonary hypertensionRespiratory, thoracic and mediastinal disordersPlacebo42,679
seriousPulmonary hypertensionRespiratory, thoracic and mediastinal disordersAlogliptin42,701
seriousPleural effusionRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousPleural effusionRespiratory, thoracic and mediastinal disordersAlogliptin42,701
seriousPulmonary fibrosisRespiratory, thoracic and mediastinal disordersPlacebo32,679
seriousPulmonary fibrosisRespiratory, thoracic and mediastinal disordersAlogliptin22,701
seriousInterstitial lung diseaseRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousInterstitial lung diseaseRespiratory, thoracic and mediastinal disordersAlogliptin32,701
seriousAcute respiratory distress syndromeRespiratory, thoracic and mediastinal disordersPlacebo12,679
seriousAcute respiratory distress syndromeRespiratory, thoracic and mediastinal disordersAlogliptin22,701
seriousAsthmaRespiratory, thoracic and mediastinal disordersPlacebo22,679
seriousAsthmaRespiratory, thoracic and mediastinal disordersAlogliptin12,701

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=30

API referenceFor AI assistants